Insights On Regulatory Compliance

  1. The Strategic Power Of Medical Device Coatings 2/24/2026

    Medical device coatings are shifting from basic finishes to strategic tools that boost performance, safety, sustainability, and innovation through stronger partnerships, smarter materials, and collaborative development.

  2. Successful Tech Transfer Meets Commercial Needs 5/5/2026

    An accelerated technology transfer reduced time to PPQ by over 25%, overcoming novel raw materials, unique IP constraints, and late‑stage process optimization to meet urgent commercial demand.

  3. Be Smart: Flexible Production With Module Type Package (MTP) 4/29/2026

    Modular production is moving from vision to practice. Learn how the Module Type Package enables flexible manufacturing while unlocking valuable process data based on real implementation experience.

  4. Maximizing Results For Viral Clearance Studies 7/25/2025

    Explore virus strain selection and titer strategies to optimize viral clearance studies, covering regulatory expectations, study design, and execution best practices.

  5. How AI-Enabled Validation Technologies Enable The Predictive Plant 3/18/2026

    Discover how AI-enabled digital validation shifts manufacturers from reactive compliance to predictive intelligence, connecting validation, asset, and quality data to accelerate digital maturity.

  6. The History Of Chemical Nomenclature And ACD/Name 6/18/2026

    Modern chemical naming requires algorithmic precision to match evolving standards and new compound classes. Up-to-date nomenclature ensures regulatory compliance and seamless workflow integration.

  7. Collaborative Supply Chain Management In A Fragmented World 6/15/2026

    Biopharma supply chains are under pressure. As regionalization accelerates, success depends on agility, trust, and new approaches to collaboration that can withstand ongoing global uncertainty.

  8. Calculating The ROI Of EAM/CMMS For Pharma Manufacturers And CDMOs 10/6/2025

    Learn how modern EAM and CMMS systems help pharma manufacturers reduce risk, improve compliance, and cut costs, as well as nine signs it’s time to move beyond outdated asset management practices.

  9. A Risk-Based Decision Framework For Selecting Aseptic Barrier Technologies 3/20/2026

    EU GMP Annex 1 requires a risk-based approach to selecting Isolators or RABS. This framework evaluates human intervention and decontamination to ensure robust sterility assurance.

  10. A CDMO Is The Nexus Between Green Chemistry And Commercialization 2/24/2026

    Modern R&D transforms sustainability from an optional add-on into a strategic optimization tool, enhancing cost-efficiency, speed to market, and process intensification for drug developers.